IL1B and colitis: After mice with TNBS-induced colitis were treated by intragastric administration of ginsenoside Rb1, the levels of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) declined, while the levels of anti-inflammatory cytokines (IL-10) increased [50].